Page 11 - Pfizer

Pfizer to acquire Arena Pharmaceuticals at 100% premium in $6.7-bn deal

The U.S. drugmaker will pay $100 a share in an all-cash transaction for San Diego-based Arena, bringing assets in gastroenterology, dermatology and cardiology

Booster shot of Pfizer can cut mortality from Delta variant by 90%: Study

The third dose of the Pfizer Covid-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel.

Three-shot course of Pfizer's Covid-19 vaccine neutralises Omicron variant

BioNTech and Pifzer are the first manufacturers of a Covid vaccine to issue an official update on the efficacy of their shot against Omicron

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

A booster with the current version of the vaccine increased antibodies 25-fold, providing a similar level as observed after two doses

Pfizer vaccine may only partially protect against Omicron variant: Study

South Africa research shows that blood from people who had received two doses of the vaccine and had a prior infection were mostly able to neutralise the variant.

Pfizer faces scrutiny over scale of its Covid profits, says report

Pfizer has to date pledged 40m doses out of global production to Covax

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines.

Delta variant may have increased ability to evade vaccine immunity: Study

Vaccines are effective in decreasing hospitalization and deaths from Covid-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a recent study.

UK study finds mRNA Covid-19 vaccines provide biggest booster impact

Pfizer and Moderna shots give large antibody boosts regardless of whether a person initially received those vaccines.

Pfizer working on updated jab in response to Omicron variant: CEO

Pfizer's chief executive Dr Albert Bourla said he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease

Pfizer begins application for Canada's approval of Covid-19 pill

The country has identified seven people with the new variant as of Nov. 30.

Pfizer, BioNTech unsure of vax effectiveness against new Covid variant

The companies also promised to develop a new vaccine against the variant in about 100 days

LIVE: 25 killed, 17 missing as flash floods ravage Andhra Pradesh

In Kadiri town in Anantapuramu district, a building under construction collapsed due to incessant rain and fell on an adjoining one, killing at least five persons, including two children

Canada to allow entry to those vaccinated with Sinopharm, Sinovac, Covaxin

Currently, Canada only accepts travellers who have received the vaccines, including Pfizer, Moderna, AstraZeneca and Johnson and Johnson

FDA authorises Pfizer, Moderna Covid-19 vaccine boosters for US adults

The regulator's decision paves the way for millions of Americans to get additional protection

Pfizer signs $5.3-bn deal with US govt for 10 mn Covid-19 pills

The oral drug could be a promising new weapon in the fight against the pandemic

FDA plans to authorise Pfizer boosters for adults this week: Report

The Food and Drug Administration is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday

Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco

Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders

Pfizer to allow generic versions of its Covid-19 pill in 95 countries

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers

Pfizer's anti-Covid pill can be made by Indian drug firms without royalties

Pharma major will waive royalties on sales in all countries covered by the MPP agreement apart from poor nations